Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Inhibition of type I NKT cells by retinoids or following sulfatide-mediated activation of type II NKT cells attenuates alcoholic liver disease.

Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews KS, Gao B, Kumar V.

Hepatology. 2014 Dec 5. doi: 10.1002/hep.27632. [Epub ahead of print]

PMID:
25477000
[PubMed - as supplied by publisher]
2.

Neurotropin Suppresses Inflammatory Cytokine Expression and Cell Death through Suppression of NF-κB and JNK in Hepatocytes.

Zhang B, Roh YS, Liang S, Liu C, Naiki M, Masuda K, Seki E.

PLoS One. 2014 Dec 3;9(12):e114071. doi: 10.1371/journal.pone.0114071. eCollection 2014.

PMID:
25470242
[PubMed - in process]
Free PMC Article
3.

The TM6SF2 Variants, Novel Genetic Predictors for Nonalcoholic Steatohepatitis.

Roh YS, Loomba R, Seki E.

Gastroenterology. 2014 Nov 18. pii: S0016-5085(14)01417-6. doi: 10.1053/j.gastro.2014.11.014. [Epub ahead of print] No abstract available.

PMID:
25451657
[PubMed - as supplied by publisher]
4.

Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis.

Patel NS, Doycheva I, Peterson MR, Hooker J, Kisselva T, Schnabl B, Seki E, Sirlin CB, Loomba R.

Clin Gastroenterol Hepatol. 2014 Sep 15. pii: S1542-3565(14)01316-0. doi: 10.1016/j.cgh.2014.08.039. [Epub ahead of print]

PMID:
25218667
[PubMed - as supplied by publisher]
5.

ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development.

Nakagawa H, Umemura A, Taniguchi K, Font-Burgada J, Dhar D, Ogata H, Zhong Z, Valasek MA, Seki E, Hidalgo J, Koike K, Kaufman RJ, Karin M.

Cancer Cell. 2014 Sep 8;26(3):331-43. doi: 10.1016/j.ccr.2014.07.001. Epub 2014 Aug 14.

PMID:
25132496
[PubMed - indexed for MEDLINE]
6.

Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways.

Seki E, Schwabe RF.

Hepatology. 2014 Jul 26. doi: 10.1002/hep.27332. [Epub ahead of print]

PMID:
25066777
[PubMed - as supplied by publisher]
7.

GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis.

Lopez-Sanchez I, Dunkel Y, Roh YS, Mittal Y, De Minicis S, Muranyi A, Singh S, Shanmugam K, Aroonsakool N, Murray F, Ho SB, Seki E, Brenner DA, Ghosh P.

Nat Commun. 2014 Jul 21;5:4451. doi: 10.1038/ncomms5451.

PMID:
25043713
[PubMed - in process]
8.

TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.

Inokuchi-Shimizu S, Park EJ, Roh YS, Yang L, Zhang B, Song J, Liang S, Pimienta M, Taniguchi K, Wu X, Asahina K, Lagakos W, Mackey MR, Akira S, Ellisman MH, Sears DD, Olefsky JM, Karin M, Brenner DA, Seki E.

J Clin Invest. 2014 Aug 1;124(8):3566-78. doi: 10.1172/JCI74068. Epub 2014 Jul 1.

PMID:
24983318
[PubMed - in process]
Free PMC Article
9.

Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.

Umemura A, Park EJ, Taniguchi K, Lee JH, Shalapour S, Valasek MA, Aghajan M, Nakagawa H, Seki E, Hall MN, Karin M.

Cell Metab. 2014 Jul 1;20(1):133-44. doi: 10.1016/j.cmet.2014.05.001. Epub 2014 Jun 5.

PMID:
24910242
[PubMed - in process]
10.

Novel fate-tracing strategies show that hepatic stellate cells mediate fibrosis in vivo.

Liang S, Zhong Z, Seki E.

Gastroenterology. 2014 Jun;146(7):1823-5. doi: 10.1053/j.gastro.2014.04.010. Epub 2014 Apr 21. No abstract available.

PMID:
24768331
[PubMed - indexed for MEDLINE]
11.

Microbiome-obesity-liver cancer interaction: senescence of hepatic stellate cells and bile acids play new roles.

Seki E.

Gastroenterology. 2014 Mar;146(3):860-1. doi: 10.1053/j.gastro.2014.01.029. Epub 2014 Jan 24. No abstract available.

PMID:
24468171
[PubMed - indexed for MEDLINE]
12.

Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells.

Liu C, Chen X, Yang L, Kisseleva T, Brenner DA, Seki E.

J Biol Chem. 2014 Mar 7;289(10):7082-91. doi: 10.1074/jbc.M113.543769. Epub 2014 Jan 21.

PMID:
24448807
[PubMed - indexed for MEDLINE]
13.

Reply: To PMID 23996730.

Yang L, Seki E.

Hepatology. 2014 Sep;60(3):1114-5. doi: 10.1002/hep.27019. Epub 2014 Jul 28. No abstract available.

PMID:
24443149
[PubMed - indexed for MEDLINE]
14.

TAK1 regulates hepatic cell survival and carcinogenesis.

Roh YS, Song J, Seki E.

J Gastroenterol. 2014 Feb;49(2):185-94. doi: 10.1007/s00535-013-0931-x. Epub 2014 Jan 21. Review.

PMID:
24443058
[PubMed - indexed for MEDLINE]
15.

NCOA5, IL-6, type 2 diabetes, and HCC: The deadly quartet.

Dhar D, Seki E, Karin M.

Cell Metab. 2014 Jan 7;19(1):6-7. doi: 10.1016/j.cmet.2013.12.010.

PMID:
24411937
[PubMed - indexed for MEDLINE]
16.

Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.

Roh YS, Park S, Kim JW, Lim CW, Seki E, Kim B.

Hepatology. 2014 Jul;60(1):237-49. doi: 10.1002/hep.26981. Epub 2014 May 27.

PMID:
24375615
[PubMed - indexed for MEDLINE]
17.

Nrf2 activation protects the liver from ischemia/reperfusion injury in mice.

Kudoh K, Uchinami H, Yoshioka M, Seki E, Yamamoto Y.

Ann Surg. 2014 Jul;260(1):118-27. doi: 10.1097/SLA.0000000000000287.

PMID:
24368646
[PubMed - indexed for MEDLINE]
18.

Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls.

Patel NS, Peterson MR, Lin GY, Feldstein A, Schnabl B, Bettencourt R, Seki E, Sirlin CB, Loomba R.

Gastroenterol Res Pract. 2013;2013:498296. doi: 10.1155/2013/498296. Epub 2013 Nov 17.

PMID:
24348536
[PubMed]
Free PMC Article
19.

A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse.

Moles A, Murphy L, Wilson CL, Chakraborty JB, Fox C, Park EJ, Mann J, Oakley F, Howarth R, Brain J, Masson S, Karin M, Seki E, Mann DA.

J Hepatol. 2014 Apr;60(4):782-91. doi: 10.1016/j.jhep.2013.12.005. Epub 2013 Dec 11.

PMID:
24333183
[PubMed - in process]
Free PMC Article
20.

Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis.

Motomura H, Matsushita I, Seki E, Mine H, Kimura T.

Int J Rheum Dis. 2014 Sep;17(7):747-52. doi: 10.1111/1756-185X.12227. Epub 2013 Nov 20.

PMID:
24251619
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk